To align our experimental models with the molecular subtypes of SCLC, we sought to characterize the subtype of our preclinical SCLC models by examining the expression of the three defining genes: ASCL1, NEUROD1, and POU2F3. Here, NEUROD1 is linked to small cell lung carcinoma.